ESC Premium Access

A real-world assessment of the distribution of lipid levels across increasing lipoprotein(a) levels in patients with established cardiovascular disease in the United States

Congress Presentation

About the speaker

Doctor Ana Filipa Fonseca

Novartis Sweden AB, Stockholm (Sweden)
0 follower

217 more presentations in this session

The association between napping and the risk of cardiovascular disease and all-cause mortality: a systematic review and dose-response meta-analysis

Speaker: Doctor Z. Pan (Guangzhou, CN)

Thumbnail

Prediction of 10-year and lifetime risk of cancer in individual patients with established cardiovascular disease, results from UCC-SMART and CANTOS

Speaker: Miss C. van 't Klooster (Utrecht, NL)

Thumbnail

Geographical profiles of cardiovascular risk and the risk factors in China: data from a nationwide population-based screening project

Speaker: Assistant Professor C. Wu (Beijing, CN)

Thumbnail

Associations between life-course frailty and later-life heart size and function in the 1946 NSHD British birth cohort-an epidemiological study

Speaker: Mr C. Topriceanu (London, GB)

Thumbnail

Lipoprotein(a) and cardiovascular disease: prediction, attributable risk fraction and estimating benefits from novel interventions

Speaker: Doctor P. Welsh (Glasgow, GB)

Thumbnail

Access the full session

Risk Factors and Prevention ePosters

Speakers: Doctor A. Fonseca, Doctor Z. Pan, Miss C. van 't Klooster, Assistant Professor C. Wu, Mr C. Topriceanu...
Thumbnail

About the event

Image

ESC Congress 2020

29 August - 1 September 2020

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb